Selected research
Industry Research
Furazolidone Industry Research Report 2026
Market perspective
The global Furazolidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Furazolidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Furazolidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Furazolidone include Becton, Dickinson and Company (BD), Daiichi Sankyo, Ferring, Geo-Med, GrÜNenthal Gmbh, Keyfarm, KPL Pharma, Marvi and Standpharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Furazolidone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Furazolidone Market by Company
Becton, Dickinson and Company (BD)
Daiichi Sankyo
Ferring
Geo-Med
GrÜNenthal Gmbh
Keyfarm
KPL Pharma
Marvi
Standpharm
Teva
Furazolidone Segment by Type
Pharma Grade
Industrial Grade
Others
Furazolidone Segment by Application
Pharmacy
Industry
Furazolidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furazolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Furazolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furazolidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Furazolidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Furazolidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Furazolidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharma Grade
- Industrial Grade
- Others
Applications
- Pharmacy
- Industry
Companies covered
- Becton, Dickinson and Company (BD)
- Daiichi Sankyo
- Ferring
- Geo-Med
- GrÜNenthal Gmbh
- Keyfarm
- KPL Pharma
- Marvi
- Standpharm
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Furazolidone Market Size (2021-2032)
- 2.2.2 Global Furazolidone Sales (2021-2032)
- 2.2.3 Global Furazolidone Market Average Price (2021-2032)
- 2.3 Furazolidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharma Grade
- 2.3.3 Industrial Grade
- 2.3.4 Others
- 2.4 Furazolidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmacy
- 2.4.3 Industry
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Furazolidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Furazolidone Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Furazolidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Furazolidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Furazolidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Furazolidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Furazolidone, Product Type & Application
- 3.8 Global Manufacturers of Furazolidone, Established Date
- 3.9 Global Furazolidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Becton, Dickinson and Company (BD)
- 4.1.1 Becton, Dickinson and Company (BD) Company Information
- 4.1.2 Becton, Dickinson and Company (BD) Business Overview
- 4.1.3 Becton, Dickinson and Company (BD) Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Becton, Dickinson and Company (BD) Furazolidone Product Portfolio
- 4.1.5 Becton, Dickinson and Company (BD) Recent Developments
- 4.2 Daiichi Sankyo
- 4.2.1 Daiichi Sankyo Company Information
- 4.2.2 Daiichi Sankyo Business Overview
- 4.2.3 Daiichi Sankyo Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Daiichi Sankyo Furazolidone Product Portfolio
- 4.2.5 Daiichi Sankyo Recent Developments
- 4.3 Ferring
- 4.3.1 Ferring Company Information
- 4.3.2 Ferring Business Overview
- 4.3.3 Ferring Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ferring Furazolidone Product Portfolio
- 4.3.5 Ferring Recent Developments
- 4.4 Geo-Med
- 4.4.1 Geo-Med Company Information
- 4.4.2 Geo-Med Business Overview
- 4.4.3 Geo-Med Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Geo-Med Furazolidone Product Portfolio
- 4.4.5 Geo-Med Recent Developments
- 4.5 GrÜNenthal Gmbh
- 4.5.1 GrÜNenthal Gmbh Company Information
- 4.5.2 GrÜNenthal Gmbh Business Overview
- 4.5.3 GrÜNenthal Gmbh Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GrÜNenthal Gmbh Furazolidone Product Portfolio
- 4.5.5 GrÜNenthal Gmbh Recent Developments
- 4.6 Keyfarm
- 4.6.1 Keyfarm Company Information
- 4.6.2 Keyfarm Business Overview
- 4.6.3 Keyfarm Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Keyfarm Furazolidone Product Portfolio
- 4.6.5 Keyfarm Recent Developments
- 4.7 KPL Pharma
- 4.7.1 KPL Pharma Company Information
- 4.7.2 KPL Pharma Business Overview
- 4.7.3 KPL Pharma Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KPL Pharma Furazolidone Product Portfolio
- 4.7.5 KPL Pharma Recent Developments
- 4.8 Marvi
- 4.8.1 Marvi Company Information
- 4.8.2 Marvi Business Overview
- 4.8.3 Marvi Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Marvi Furazolidone Product Portfolio
- 4.8.5 Marvi Recent Developments
- 4.9 Standpharm
- 4.9.1 Standpharm Company Information
- 4.9.2 Standpharm Business Overview
- 4.9.3 Standpharm Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Standpharm Furazolidone Product Portfolio
- 4.9.5 Standpharm Recent Developments
- 4.10 Teva
- 4.10.1 Teva Company Information
- 4.10.2 Teva Business Overview
- 4.10.3 Teva Furazolidone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Furazolidone Product Portfolio
- 4.10.5 Teva Recent Developments
5 Global Furazolidone Market Scenario by Region
- 5.1 Global Furazolidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Furazolidone Sales by Region: 2021-2032
- 5.2.1 Global Furazolidone Sales by Region: 2021-2026
- 5.2.2 Global Furazolidone Sales by Region: 2027-2032
- 5.3 Global Furazolidone Revenue by Region: 2021-2032
- 5.3.1 Global Furazolidone Revenue by Region: 2021-2026
- 5.3.2 Global Furazolidone Revenue by Region: 2027-2032
- 5.4 North America Furazolidone Market Facts & Figures by Country
- 5.4.1 North America Furazolidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Furazolidone Sales by Country (2021-2032)
- 5.4.3 North America Furazolidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Furazolidone Market Facts & Figures by Country
- 5.5.1 Europe Furazolidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Furazolidone Sales by Country (2021-2032)
- 5.5.3 Europe Furazolidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Furazolidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Furazolidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Furazolidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Furazolidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Furazolidone Market Facts & Figures by Country
- 5.7.1 South America Furazolidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Furazolidone Sales by Country (2021-2032)
- 5.7.3 South America Furazolidone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Furazolidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Furazolidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Furazolidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Furazolidone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Furazolidone Sales by Type (2021-2032)
- 6.1.1 Global Furazolidone Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Furazolidone Sales Market Share by Type (2021-2032)
- 6.2 Global Furazolidone Revenue by Type (2021-2032)
- 6.2.1 Global Furazolidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Furazolidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Furazolidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Furazolidone Sales by Application (2021-2032)
- 7.1.1 Global Furazolidone Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Furazolidone Sales Market Share by Application (2021-2032)
- 7.2 Global Furazolidone Revenue by Application (2021-2032)
- 7.2.1 Global Furazolidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Furazolidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Furazolidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Furazolidone Value Chain Analysis
- 8.1.1 Furazolidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Furazolidone Production Mode & Process
- 8.2 Furazolidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Furazolidone Distributors
- 8.2.3 Furazolidone Customers
9 Global Furazolidone Analyzing Market Dynamics
- 9.1 Furazolidone Industry Trends
- 9.2 Furazolidone Industry Drivers
- 9.3 Furazolidone Industry Opportunities and Challenges
- 9.4 Furazolidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst